Focusing on the fact that YAP expression is up-regulated in the IEC of IBD patients, the therapeutic effect of YAP-targeting microRNA miR-590-5p as well as YAP inhibitor verteporfin in the TNBS model was investigated [139]. The gene discussed is YAP1; the disease is inflammatory bowel disease.